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Mouse Hepatocyte Overexpression of NF-jB-Inducing
Kinase (NIK) Triggers Fatal Macrophage-Dependent
Liver Injury and Fibrosis
Hong Shen, Liang Sheng, Zheng Chen, Lin Jiang, Haoran Su, Lei Yin, M. Bishr Omary, and Liangyou Rui
Damaged, necrotic, or apoptotic hepatocytes release damage-associated molecular patterns
that initiate sterile inflammation, and liver inflammation drives liver injury and fibrosis.
Here we identified hepatic nuclear factor kappa B (NF-jB)-inducing kinase (NIK), a Ser/
Thr kinase, as a novel trigger of fatal liver inflammation. NIK is activated by a broad
spectrum of stimuli. It was up-regulated in injured livers in both mice and humans. In
primary mouse hepatocytes, NIK overexpression stimulated, independently of cell injury
and death, release of numerous chemokines and cytokines that activated bone marrow-
derived macrophages (BMDMs). BMDMs in turn secreted proapoptotic molecules that
stimulated hepatocyte apoptosis. Hepatocyte-specific expression of the NIK transgene trig-
gered massive liver inflammation, oxidative stress, hepatocyte apoptosis, and liver fibrosis,
leading to weight loss, hypoglycemia, and death. Depletion of Kupffer cells/macrophages
reversed NIK-induced liver destruction and death. Conclusion: the hepatocyte NIK-liver
immune cell axis promotes liver inflammation, injury, and fibrosis, thus driving liver dis-
ease progression. (HEPATOLOGY 2014;60:2065-2076)
T
he liver regulates many vital physiological proc-
esses, and liver inflammation plays a critical
pathological role in liver disease progression.1-4
Injured, necrotic, and apoptotic hepatocytes release
damage-associated molecular patterns (DAMPs) which
are believed to initiate liver inflammation.2-4 Hepato-
cytes also express cytokines and chemokines5-7; how-
ever, their contributions to liver disease are not fully
understood.
We recently reported that nonalcoholic fatty liver
disease (NAFLD) is associated with abnormal activa-
tion of nuclear factor kappa B (NF-jB)-inducing
kinase (NIK, also called MAP3K14) in the liver.8 NIK
is a ubiquitously expressed Ser/Thr kinase, and its lev-
els are very low due to rapid proteasome-mediated
degradation.9,10 In quiescent cells, the TRAF2/TRAF3
adaptor protein complex binds to NIK and recruits
NIK to cIAP1/2 ubiquitin E3 ligases, resulting in NIK
ubiquitination and degradation.10-12 NIK is activated
by diverse stimuli, including oxidative stress, saturated
fatty acids, cytokines, endotoxins, as well as ligands
that activate Toll-like receptors (TLRs), receptor tyro-
sine kinases, and G-protein-coupled receptors.8,13-18
Cytokines stimulate TRAF3 degradation, leading to
NIK stabilization and activation.19,20 NIK is required
for the activation of the noncanonical NF-jB2 signal-
ing pathway.21 It phosphorylates and activates I-jB
kinasea (IKKa), which in turn phosphorylates the
p100 form of NF-jB2.22,23 Phosphorylation of p100
promotes its proteolytic cleavage to generate the
mature p52 form of NF-jB2.13,21,23
NIK is known to regulate lymphocyte development
and adaptive immunity.13,14 We asked whether NIK in
hepatocytes is involved in regulating liver inflamma-
tion, integrity, and function. We generated and charac-
terized new mouse models with hepatocyte-specific
overexpression of the NIK transgene, and examined
NIK-induced crosstalk between hepatocytes and
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immune cells. Our data demonstrate that hepatic NIK
is a previously unknown regulator of liver inflamma-
tion and liver integrity.
Materials and Methods
Animals. Mice were housed on a 12-hour light-
dark cycle in the Unit for Laboratory Animal Medicine
at the University of Michigan. Animal experiments
were conducted following the protocols approved by
the University Committee on the Use and Care of
Animals.
STOP-Tomato reporter mice and albumin-Cre trans-
genic mice (C57BL/6 background) were from the
Jackson Laboratory (Bar Harbor, ME). STOP-NIK
mice (C57BL/6 background) were kindly provided by
Dr. Klaus Rajewsky (Harvard Medical School, Boston,
MA).24 Adult STOP-NIK mice were infected with
albumin-Cre adenoviruses or AAV-Cre by way of tail
vein injection to activate the NIK transgene specifically
in hepatocytes. Alternatively, STOP-NIK mice were
crossed with albumin-Cre transgenic mice to specifi-
cally activate the NIK transgene in hepatocytes of
STOP-NIK and albumin-Cre double transgenic mice.
Kupffer cells/macrophages were depleted by GdCl3
treatments as reported previously.25,26
Immunostaining, Immunoblotting, and Quantita-
tive Polymerase Chain Reaction (qPCR). Liver par-
affin or frozen sections were prepared and
immunostained with the indicated antibodies. Liver
extracts were blotted with the indicated antibodies.
Liver mRNA abundance was quantified by qPCR.
Primary Hepatocyte Cultured and Cell Death
Assays. Primary hepatocytes were prepared from
mice, and were either grown alone or cocultured with
BMDMs. Cell death was measured by terminal deoxy-
nucleotidyl transferase dUTP nick end labeling
(TUNEL) assays.
Detailed methods are described in the Supporting
Materials.
Statistics. Data are presented as means6 SEM.
Differences between groups were analyzed with two-
tailed Student t test. P< 0.05 was considered statisti-
cally significant.
Results
NIK Is Aberrantly Activated in Damaged Livers
in Mice and Humans. Liver injury was induced by
treating mice with carbon tetrachloride (CCl4) or alco-
hol. Both CCl4 and 3-week alcohol treatments signifi-
cantly increased NIK mRNA levels (Fig. 1A,B).
Hepatic NIK protein was undetectable by commercial
antibodies,8,10 so we estimated NIK activation by
examining the noncanonical NF-jB2 pathway. Both
CCl4 treatments and chronic alcohol consumption
markedly increased the amounts of the p52 form of
NF-jB2 (Fig. 1D,E). We asked whether hepatic NIK
is overactivated in human liver disease. Liver biopsies
were obtained from normal subjects and patients with
alcoholic cirrhosis or primary biliary cirrhosis (PBC).
The levels of both NIK mRNA (Fig. 1C) and p52
protein (Fig. 1F) were higher in cirrhotic livers.
Adult-Onset, Hepatocyte-Specific Activation of NIK
Causes Liver Dysfunction and Death in Mice. To
examine the role of NIK, we obtained STOP-NIK
mice in which a “STOP-NIK” transgenic cassette was
inserted into the Rosa26 locus.24 Cre-mediated incision
of the “STOP” sequences, which are flanked by a loxp
site at both ends, is expected to activate the NIK trans-
gene whose expression is under the control of the
endogenous Rosa26 promoter.8,24 We generated albu-
min-Cre adenoviruses in which Cre expression is under
the control of the mouse albumin promoter. To vali-
date the adenoviruses, STOP-Tomato reporter mice,
which had a similar STOP-Tomato knockin cassette at
the Rosa26 locus, were infected with albumin-Cre
adenoviruses by way of tail vein injection. Liver sec-
tions were immunostained with antibodies against
keratin-18 (a liver epithelial cell marker), keratin-19 (a
cholangiocyte marker), or F4/80 (a Kupffer cell/macro-
phage marker). Tomato-red fluorescence was detected
only in hepatocytes but not in cholangiocytes, Kupffer
cells, and macrophages (Supporting Fig. S1A).
Tomato-red fluorescence was also detected in purified
primary hepatocytes (albumin- and K18-positive cells)
(Figs. S1B-C).
STOP-NIK mice (8-9 weeks old) were infected with
albumin-Cre or green fluorescent protein (GFP)
adenoviruses by way of tail vein injection.
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Recombinant NIK (with an N-terminal Flag tag) and
high levels of p52 were detected in the livers of Cre,
but not GFP, adenovirus-infected mice (Fig. 2A,B).
Recombinant NIK was absent in the heart, adipose tis-
sue, kidney, and skeletal muscle (Fig. 2A). Mice with
hepatocyte-specific overexpression of NIK progressively
lost body weight, developed hypoglycemia, and died
gradually with 90% lethality 27 days after infection
(Fig. 2C). In contrast, none of the GFP adenovirus-
infected mice died 27 days after infection, which was
the extent of time the animals were followed. The
activity of serum alkaline phosphatase (ALP) and ala-
nine aminotransferase (ALT) and the levels of total bil-
irubin were significantly higher in Cre than in GFP
groups (Fig. 2D). As a control, albumin-Cre-infected
wild-type (WT) mice did not have weight loss, hypo-
glycemia, and liver injury (Fig. S2A,B). To verify these
observations, we infected STOP-NIK mice with AAV-
Cre. NIK was specifically overexpressed in the liver
(Fig. S3A), and caused weight loss, hypoglycemia, and
fatal liver injury (Fig. 2E,F). These findings indicate
that hepatocyte-specific overexpression of NIK is suffi-
cient to cause lethal liver injury.
Adult-Onset Overexpression of NIK in Hepato-
cytes Promotes Liver Oxidative Stress and Hepato-
cyte Apoptosis in Mice. Hepatocyte-specific
overexpression of NIK caused hepatomegaly in STOP-
NIK mice infected with either albumin-Cre (Fig. 3A)
or AAV-Cre (Fig. S3B). The liver architectures were
disrupted, with many damaged ballooned hepatocytes
and massive immune cell infiltration (Fig. 3B; Fig.
S3C). The number of apoptotic liver cells, measured
by TUNEL assays, was significantly higher in NIK-
overexpressing mice (Fig. 3C,D). The amount of active
caspase-3 (casp3), apoptotic keratin-18 fragment, and
phosphorylated JNKs were also higher (Fig. 3E). Apo-
ptotic keratin-18 fragments have been used to estimate
hepatocyte death.27 The levels of reactive oxygen spe-
cies (ROS) were significantly higher in both albumin-
Cre and AAV-Cre groups (Fig. 3F). By contrast, albu-
min-Cre infection did not cause hepatomegaly, liver
oxidative stress, inflammation, and hepatocyte apopto-
sis in WT mice (Fig. S2B-E). These observations sug-
gest that hepatocyte-specific overexpression of NIK
promotes liver oxidative stress and hepatocyte apopto-
sis, leading to fatal liver injury.
Fig. 1. Liver injury is associated
with increased activation of hepatic
NIK. (A,B) Liver NIK expression was
quantified by qPCR and normalized to
18S levels. Con: n5 4, CCl4: n5 7;
Con: n5 4, alcohol: n5 5. (C) NIK
mRNA levels were measured by qPCR
in human liver samples and normal-
ized to GAPDH levels. Con: n5 2;
ALD: n5 6; PBC: n5 3. (D,E) Liver
extracts were immunoblotted with anti-
bodies against NF-jB2 or tubulin. (F)
Liver extracts were prepared from
human samples and immunoblotted
with anti-NF-jB2 antibody. The same
blots were stained with Coomassie
blue to visualize total proteins.
*P< 0.05.
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Adult-Onset, Hepatocyte-Specific Overexpression of
NIK Causes Liver Inflammation and Fibrosis. To
examine liver inflammation, liver sections were immu-
nostained with antibodies to F4/80, CD45, or CD3.
Kupffer cell/macrophage number was significantly
higher in albumin-Cre (Fig. 4A) and AAV-Cre groups
(Fig. S3D,E). The numbers of CD45-positive and
CD3-positive cells were also higher in the albumin-Cre
group (Fig. S4). The expression of liver chemokines
(e.g., CCL2, CCL5, and CXCL5), proinflammatory
cytokines (e.g., tumor necrosis factor alpha [TNFa]
and interleukin [IL]-6), and inducible nitric oxide
synthase (iNOS) was much higher in albumin-Cre
than in GFP adenovirus-infected mice (Fig. 4B). To
examine liver fibrosis, liver sections were stained with
Sirius-red. Liver fibrillar collagen was barely detectible
in the GFP group, but very abundant in both albu-
min-Cre (Fig. 4C) and AAV-Cre groups (Fig. S3C).
Liver hydroxyproline content, an index to estimate
liver fibrosis, was significantly higher in both albumin-
Fig. 2. Adult-onset, hepatocyte-specific overexpression of NIK causes lethal liver injury. (A,B) STOP-NIK mice were infected with GFP (Con) or
albumin-Cre adenoviruses by way of tail vein injection. Tissue extracts were immunoblotted with the indicated antibodies. (C) Body weight (Con:
n5 6; Cre: n5 6), nonfasting blood glucose (Con: n5 4; Cre: n5 4), and survival curves (Con: n5 4; Cre: n5 5). (D) Plasma ALT and ALP
activity and total bilirubin levels 18 days after infection. Con: n5 6; Cre: n5 5. (E) STOP-NIK mice were infected with AAV-GFP or AAV-Cre, and
body weight and nonfasting blood glucose were monitored. AAV-GFP: n5 3; AAV-Cre: n5 3. (F) Plasma ALT activity and total bilirubin levels
were measured 9 days after infection. AAV-GFP: n5 3; AAV-Cre: n5 3. *P< 0.05.
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Fig. 4. Adult-onset, hepatocyte-specific overexpression of NIK
causes liver inflammation and fibrosis. STOP-NIK males were sacrificed
18 days after GFP (Con) or albumin-Cre adenoviral infection. (A) Liver
sections were immunostained with anti-F4/80 antibody. F4/80-positive
cells were normalized to DAPI-positive cells. Con: n5 6; Cre: n5 5.
(B) The abundance of hepatic mRNAs (normalized to 18S levels).
Con: n5 5-6; Cre: n5 6. (C) Liver sections were stained with Sirius-
red/fast green. Sirius-red-positive areas were normalized to total
microscopic areas. Con: n5 6; Cre; n5 6. (D) Liver hydroxyproline
levels (normalized to liver weight). Con: n5 6; Cre, n5 6. (E) Liver
extracts were immunoblotted with antibodies against a-SMA or p85.
(F) Liver sections were immunostained with antibody to a-SMA. a-
SMA-positive areas were normalized to microscopic areas. Con: n5 4;
Cre: n5 4. *P< 0.05.
Fig. 3. Adult-onset, hepatocyte-specific overexpression of NIK
causes liver oxidative stress and hepatocyte death. (A-C) STOP-NIK
males were sacrificed 18 days after GFP (Con) or albumin-Cre adeno-
viral infection. (A) Liver weight. BW: body weight. Con: n5 6; Cre:
n5 6. (B) Hematoxylin and eosin (H&E) staining of liver sections. (C)
Liver sections were costained with TUNEL reagents and 40-6-diamidino-
2-phenylindole (DAPI). Inserts: enlarged merged images. TUNEL-
positive cells were normalized to DAPI-positive cells. Con: n5 5; Cre:
n5 5. (D) STOP-NIK mice were infected with AAV-GFP or AAV-Cre, and
liver sections (9 days after infection) were stained with TUNEL reagents
and DAPI. AAV-GFP: n5 3; AAV-Cre: n5 3. (E) Liver extracts (18 days
after adenoviral infection) were immunoblotted with the indicated anti-
bodies. (F) Liver ROS levels (normalized to protein levels). a.u.: arbi-
trary units. Con: n5 6; Cre: n5 5; AAV-GFP: n5 3; AAV-Cre: n5 3.
*P< 0.05.
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Cre (Fig. 4D) and AAV-Cre groups (Fig. S3B). We
measured liver a-smooth muscle actin (a-SMA), a
marker for activated myofibroblasts, by immunoblot-
ting and immunostaining. a-SMA was barely detecta-
ble in the GFP group, but readily observed in both
albumin-Cre (Fig. 4E,F) and AAV-Cre groups (Fig.
S3F). The expression of profibrotic genes (e.g.,
TGFb1, aSMA, vimentin, collagen 1a1, and TIMP) in
the liver were significantly increased by hepatocyte-
specific overexpression of NIK (Fig. 4B). In contrast,
albumin-Cre infection did not cause liver fibrosis in
WT mice (Fig. S2B-C). These data indicate that
hepatocyte-specific overexpression of NIK is sufficient
to promote liver inflammation, myofibroblast activa-
tion, and liver fibrosis.
Embryonic Onset, Hepatocyte-Specific Expression
of NIK Causes Liver Injury, Inflammation, and
Fibrosis. To further verify NIK action, we generated
NIK transgenic (Tg) mice by crossing STOP-NIK mice
with albumin-Cre mice. Both heterozygous (Tg1/–,
genotype: STOP-NIK1/–;Cre1/–) and homozygous
(Tg1/1, genotype: STOP-NIK1/1;Cre1/–) transgenic
mice were generated, and STOP-NIK mice (genotype:
STOP-NIK1/1;Cre–/–) were used as control (Con).
The NIK transgene was expressed in the livers of
Tg1/– and Tg1/1 but not Con mice, and NIK mRNA
levels were much higher in Tg1/1 than in Tg1/– mice
(Fig. S5A). The p52 form of NF-jB2 in the liver was
detected only in Tg1/1, but not in Tg1/– and Con,
mice (Fig. S5B), suggesting that a threshold level of
NIK is required for the activation of its downstream
pathways.
Tg1/1 mice gained significantly less body weight
than Tg1/– and Con mice (Fig. 5A). Tg1/– mice
were grossly normal. Like STOP-NIK mice infected
with albumin-Cre- or AAV-Cre, Tg1/1 mice became
severely ill and were euthanized after 12 weeks of
age. Serum ALT activity and bilirubin levels were sig-
nificantly higher in Tg1/1 than in Tg1/– and Con
mice (Fig. 5B). Liver function was impaired in Tg1/
1 mice as revealed by hypoglycemia (Fig. 5A). Liver
weight and ROS levels were significantly higher in
Tg1/1 than in Con mice (Fig. 5C). Tg1/1 livers
had dying hepatocytes and massive immune cell infil-
tration (Fig. 5D). Liver apoptosis was 23-fold higher
in Tg1/1 than in Con mice (Fig. 5E). Caspase-3
and JNK activation was also higher in Tg1/1 mice
(Fig. 5F).
Tg1/1 mice developed severe liver inflammation
(Fig. 6A,B; Fig. S5C,D) and fibrosis (Fig. 6C-F).
Unlike Tg1/1 mice, Tg1/– mice had neither liver
injury nor liver fibrosis (Fig. 6). Therefore, a threshold
level of hepatic NIK is required to activate lethal liver
inflammation, injury, and fibrosis.
Inflammation Mediates NIK-Induced Liver
Injury, Liver Fibrosis, and Death. We depleted
Kupffer cells/macrophages by GdCl3 treatments as
reported previously.25,26 In the H2O-treated group
(control), hepatocyte-specific overexpression of NIK
caused progressive weight loss, hypoglycemia, and
death, and GdCl3 treatment largely protected against
these detrimental effects of NIK (Fig. 7A,B). Deple-
tion of Kupffer cells/macrophages also prevented NIK-
induced liver injury (Fig. 7C). GdCl3 treatment mark-
edly decreased immune cell infiltration and Kupffer
cell/macrophage number in the liver (Fig. 7D; Fig.
S6A,B). Depletion of Kupffer cells/macrophages dra-
matically decreased NIK-induced liver oxidative stress,
apoptosis, myofibroblast activation, and fibrosis (Fig.
7D; Fig. S6B-E), and attenuated NIK-induced activa-
tion of hepatic caspase-3 and JNKs (Fig. 7E).
Hepatocyte-specific overexpression of NIK increased
the expression of proapoptotic genes (e.g., Bim, Noxa,
FAS, and DR5) in the liver, which was reversed by
GdCl3 treatments (Fig. 7F). Together, these data indi-
cate that hepatocyte-specific overactivation of NIK
triggers lethal inflammation.
Hepatic NIK Stimulates Innate Immunity Inde-
pendently of Hepatocyte Injury and Death. To
examine cell-autonomous action of hepatic NIK, we
measured hepatocyte survival (MTT assays) and apo-
ptosis (TUNEL assays). NIK was overexpressed in pri-
mary hepatocytes by way of NIK adenoviral infection,
and b-galactosidase (b-Gal) adenovirus was used as
control (Fig. 8A). NIK neither decreased survival nor
increased apoptosis; in contrast, survival rates were
higher in NIK-overexpressing hepatocytes 4 days after
infection (Fig. 8B). ROS levels and ALT release were
also similar between control and NIK-overexpressing
hepatocytes (Fig. S7A, S7C, left half ). Thus, NIK acti-
vation alone is unable to directly induce hepatocyte
injury and death.
NIK markedly increased the expression of CCL2,
CCL5, CXCL5, and TNFa in primary hepatocytes
(Fig. 8C, upper panels). We prepared conditioned
media from primary hepatocytes infected with either
b-Gal or NIK adenoviruses, and measured their ability
to activate BMDMs. NIK-conditioned medium stimu-
lated 4 to 1,600-fold higher expression of CCL2,
CCL5, CXCL5, TNFa, IL-6, and iNOS in BMDMs,
compared with b-Gal-conditioned medium; in con-
trast, the expression of IL-10, an immunosuppressive
cytokine, was 85% lower in BMDMs treated with
NIK-conditioned medium (Fig. 8C, lower panels).
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Heating treatments markedly decreased the ability of
NIK-conditioned medium to activate BMDMs (Fig.
S7B). These data indicate that hepatocyte NIK path-
ways potently stimulate the production and release of
heat-labile proinflammatory mediators, which in turn
activate innate immune cells.
Fig. 5. Embryonic onset, hepatocyte-specific overexpression of NIK causes liver oxidative stress, hepatocyte death, and liver injury. (A) Body
weight and blood glucose levels. *Con versus Tg1/1. Con: n5 5-7; Tg1/–: n5 5; Tg1/1: n5 7-9. (B) Blood ALT and total bilirubin levels at 13
weeks of age. Con: n5 7; Tg1/–: n5 3-5; Tg1/1: n5 9. (C-F) Mice were sacrificed at 13 weeks of age. (C) Liver weight and ROS levels (nor-
malized to total protein levels). Con: n5 7; Tg1/–: n5 3; Tg1/1: n5 8-9. (D) H&E staining of liver sections. (E) TUNEL-positive cells (normal-
ized to DAPI-positive cells). Con: n5 5; Tg1/1: n5 5. (F) Liver extracts were immunoblotted with the indicated antibodies. *P< 0.05.
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Aberrant Activation of Hepatic NIK Triggers a
Hepatocyte Suicide Program Through Activating
Innate Immune Cells. Primary hepatocytes were
infected with NIK or b-Gal adenoviruses and subse-
quently cocultured without (Con) or with BMDMs,
and apoptosis was measured by TUNEL assays. In the
absence of BMDMs, overexpression of NIK did not
cause apoptosis; in contrast, NIK overexpression
caused massive hepatocyte apoptosis in the presence of
BMDMs (Fig. 8D). Overexpression of NIK in
Fig. 6. Embryonic onset, hepatocyte-
specific overexpression of NIK causes
liver inflammation and fibrosis. (A) Liver
sections were immunostained with anti-
F4/80 antibody (normalized to DAPI-
positive cells). Con: n5 5; Tg1/–:
n5 3; Tg1/1: n5 5. (B) Liver mRNA
abundance. Con: n5 4-5; Tg1/–:
n5 3; Tg1/1: n5 5. (C) Liver sections
were stained with Sirius-red/fast green.
Con: n5 5; Tg1/–: n5 3; Tg1/1:
n5 6. (D) Liver hydroxyproline levels.
Con: n5 7; Tg1/–: n5 3; Tg1/1:
n5 8. (E) Liver sections were immuno-
stained with antibody to a-SMA. (F)
Liver extracts were immunoblotted with
antibodies against a-SMA or p85.
*P< 0.05.
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hepatocytes also caused hepatocyte injury, as estimated
by ALT release, in the presence, but not in the absence,
of BMDMs (Fig. S7C). To verify these results, primary
hepatocytes were isolated from STOP-NIK mice and
infected with GFP (control) or albumin-Cre adenovi-
ruses. Cre-mediated activation of the NIK transgene
also increased the expression of multiple proinflamma-
tory cytokines (Fig. S7D), and induced hepatocyte
apoptosis in a BMDM-dependent fashion (Fig. 8E
and Fig. S7E).
To gain insight into potential downstream pathways,
we generated NIKK429,430A (called KA) and G885R,
NIK mutants which lack catalytic activity and ability
to activate the noncanonical NF-jB2 pathway,
Fig. 7. Depletion of Kupffer cells/macrophages attenuates NIK’s detrimental effects. (A) Body weight (H2O: n5 6; GdCl3: n5 6) and fasting
(5 hours) blood glucose levels (18 days after albumin-Cre infection, Con: n5 6; Cre1H2O: n5 12; Cre1GdCl3: n5 6). (B) Survival rates. H2O:
n5 5; GdCl3: n5 5. (C) Plasma ALT and ALP activity and total bilirubin levels 18 days after albumin-Cre infection. H2O: n5 6-8; GdCl3: n5 6.
(D) Liver sections were stained with TUNEL, Sirius-red/fast green, or antibodies to F4/80 or a-SMA. Con: n5 4-6; Cre1H2O: n5 4-7;
Cre1GdCl3: n5 5-6. (E) Liver extracts were immunoblotted with the indicated antibodies. (F) The mRNA levels in the liver (normalized to 18S
levels). Con: n5 6; Cre1H2O: n5 6; Cre1GdCl3: n5 5. *P< 0.05.
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respectively.8,22,28 Primary hepatocytes were infected
with b-Gal, NIK, G885R, or KA adenoviruses, and
the levels of NIK, G885R, and KA were comparable
(Fig. S8A). NIK, but not G885R and KA, robustly
activated the noncanonical NF-jB2 pathway (Fig.
S8B-D). Like NIK, G885R stimulated massive hepato-
cyte apoptosis in a BMDM-dependent manner (Fig.
8D; Fig. S8E). Both NIK and G885R activated
caspase-3 in hepatocytes in a BMDM-dependent man-
ner (Fig. 8F). G885R-conditioned medium also
potently stimulated the expression of CCL2, CCL5,
CXCL5, IL-1, IL-6, TNFa, and iNOS in DMBMs
(Fig. S8F). In contrast, overexpression of KA did not
cause hepatocyte apoptosis, caspase-3 activation, and
release of proinflammatory mediators from hepatocytes
(Figs. 8D,F; Fig. S8E,F). Therefore, NIK catalytic
activity, but not its ability to activate the noncanonical
NF-jB2 pathway, is required for the NIK action in
hepatocytes.
To examine the role of the canonical NF-jB1 path-
way, we prepared conditioned medium from hepato-
cytes overexpressing constitutively-active IKKb(SE)
Fig. 8. Hepatic NIK triggers BMDM-dependent hepatocyte apoptosis. (A) Primary hepatocytes were infected with b-Gal or NIK adenoviruses.
Cell extracts were immunoblotted with the indicated antibodies. (B) Cell survival and apoptosis. MTT: Gal: n5 3, NIK: n5 3; TUNEL: Gal: n5 5;
NIK: n5 5. (C) Primary hepatocytes were infected with b-Gal (n5 3) or NIK (n5 3) adenoviruses. Gene expression was measured by qPCR 42
hours after infection. BMDMs were treated with NIK (n5 3) or b-Gal (n5 3) conditioned medium. Gene expression was measured 18 hours after
treatments. (D) Primary hepatocytes were infected with b-Gal, NIK, G885R, or KA adenoviruses and cocultured with BMDMs for 2 days. Hepato-
cytes were stained with TUNEL reagents, and TUNEL-positive cells were normalized to DAPI-positive cells. Gal: n5 5; NIK: n5 5; G855R: n5 5;
KA: n5 5. (E) Primary hepatocytes were isolated from STOP-NIK mice and infected with GFP (Con, n5 5) or albumin-Cre (n5 5) adenoviruses,
and TUNEL assays were performed in the absence or presence of BMDMs (3 days). (F) Primary hepatocytes were infected with the indicated
adenoviruses and cocultured with or without BMDMs for 2 days. Cell lysates were immunoblotted with the indicated antibodies. *P< 0.05.
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variant. IKKb(SE)-conditioned medium was unable to
stimulate the expression of CCL5 and iNOS, and was
28 to 592-fold less potent, compared with NIK-
conditioned medium, to stimulate the expression of
CCL2, CXCL5, IL-1, and IL-6 (Fig. S8F).
Discussion
In this study we established a new concept that
hepatocyte NIK pathways trigger fatal liver inflamma-
tion, leading to liver fibrosis and destruction.
Hepatic NIK Triggers Lethal Liver Inflamma-
tion. NIK-overexpressing primary hepatocytes are
not damaged, apoptotic, or necrotic, so hepatic NIK is
less likely to cause inflammation through DAMP
release. Conditioned medium from NIK-overexpressing
hepatocytes, which was sensitive to heating, robustly
stimulated BMDMs to express CCL2, CCL5, CXCL5,
TNFa, IL-6, and iNOS, indicating that NIK promotes
hepatocytes to release heat-sensitive mediators that acti-
vate immune cells. In agreement, hepatic NIK cell-
autonomously stimulated the expression of many che-
mokines and cytokines, including CCL2, CCL5,
CXCL5, and TNFa. The canonical and noncanonical
NF-jB pathways are less likely to mediate NIK action,
because G885R, which is unable to activate the nonca-
nonical NF-jB2 pathway,22,28 acted as NIK to stimulate
hepatocyte release of proinflammatory mediators,
whereas IKKb(SE), which activates the canonical NF-
jB1 pathway, was unable to do so. Unlike NIK trans-
genic mice, hepatocyte-specific IKKb transgenic mice
are viable and have normal body weight and very mild
liver injury.29 Aside from IKKa and IKKb, NIK also
phosphorylates other substrates, including CREB and
p38.8,30 Thus, NIK is likely to control a complex pro-
gram which coordinates the expression and secretion of
proinflammatory mediators. The pattern and network
of these mediators, rather than individual mediators, are
likely to trigger liver inflammation.
NIK-induced liver inflammation may develop
through several stages. Initially, NIK-stimulated, hepa-
tocyte-derived mediators trigger immune cell recruit-
ments and activation. In the second stage, immune
cell-derived mediators further recruit and activate
additional immune cells, thus forming a recruit-
ment!chemokine/cytokine release!additional
recruitment vicious cycle. Additionally, hepatocyte-
and immune cell-derived mediators may activate
hepatic stellate cells (HSCs), which in turn promote
inflammation by secreting additional proinflammatory
mediators.
NIK-Induced Inflammation Triggers Liver Injury
and Fibrosis. NIK overexpression in hepatocytes
alone was insufficient to cause apoptosis, and NIK-
expressing hepatocytes died only in the presence of
BMDMs. Moreover, depletion of Kupffer cells/macro-
phages largely eliminated NIK-induced liver oxidative
stress and hepatocyte death, and reversed liver failure
and death. These results indicate that hepatocyte NIK
signaling instructs innate immune cells by way of
hepatocyte-derived mediators, and the “educated”
immune cells subsequently execute hepatocyte death
by way of releasing hepatotoxic factors. Moreover,
NIK overexpression markedly increased the expression
of plasma membrane death receptors (e.g., FAS and
DR5) and intracellular proapoptotic molecules (e.g.,
Bim and Noxa) in the liver, suggesting that NIK sig-
naling may also increase hepatocyte sensitivity to death
signals.
Hepatocyte-specific overexpression of NIK also acti-
vated HSCs and myofibroblasts, leading to liver fibro-
sis. HSC/myofibroblast activation is likely secondary
to NIK-induced liver inflammation. However, NIK-
stimulated, hepatocyte-derived mediators may also
directly activate HSCs, contributing to liver inflamma-
tion and fibrosis.
Hepatic NIK Promotes Liver Disease Progres-
sion. The expression and activity of hepatic NIK
were higher in both rodents and humans with liver
disease. NIK may be activated by a broad spectrum of
stimuli present during liver disease progression. A
modest increase in hepatic NIK was unable to activate
liver NF-jB2 and JNK pathways and liver inflamma-
tion and fibrosis in Tg1/– mice. A further increase
caused activation of the NF-jB2 and JNK pathways
and lethal liver inflammation, fibrosis, and destruction
in homozygous Tg1/1 mice. Therefore, a threshold
level of hepatic NIK is required to fully activate the
liver destruction program.
NIK expression is very low, most likely below the
NIK threshold, in normal livers.8,10 Genetic and/or
environmental risk factors (e.g., alcohol, drugs, and
other toxins, hepatic steatosis, oxidative stress, and
inflammation) may increase hepatocyte NIK levels and
activity above the threshold, leading to activation of the
NIK destruction program. Indeed, the levels of p52 NF-
jB2 in the liver were higher in both mice and humans
with liver injury. Alternatively, these factors may lower
the NIK threshold, thus activating the NIK destruction
program. Finally, the genetic and environmental insults
may functionally interact with the subthreshold levels of
hepatic NIK in an additive or synergistic fashion to pro-
mote liver disease progression.
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In conclusion, we identified hepatic NIK as a novel
trigger of the liver inflammation and destruction pro-
gram under pathological conditions. Hepatic NIK may
serve as a therapeutic target in treating liver injury and
liver disease.
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